These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3618283)

  • 41. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated dexamethasone suppression test in depressed patients.
    Maes M; De Ruyter M; Hobin P; Suy E
    J Affect Disord; 1986; 11(2):165-72. PubMed ID: 2948992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease.
    Heuser IJ; Chase TN; Mouradian MM
    Biol Psychiatry; 1991 Nov; 30(9):943-52. PubMed ID: 1660734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1987 Nov; 22(11):1340-8. PubMed ID: 3663786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A; Kulkarni A; Yeragani VK
    Acta Psychiatr Scand; 1988 Dec; 78(6):689-94. PubMed ID: 3223326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of cortisol following dexamethasone in demented patients.
    Charles GA; Lefevre A; Mirel J; Rush AJ
    Psychiatry Res; 1986 Mar; 17(3):173-82. PubMed ID: 3704025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacologic provocation and dexamethasone suppression test sensitivity.
    Swartz CM; Breen K; Wahby VS
    Neuropsychobiology; 1989; 22(1):11-3. PubMed ID: 2700773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexamethasone suppression test in autistic children.
    Hoshino Y; Ohno Y; Murata S; Yokoyama F; Kaneko M; Kumashiro H
    Folia Psychiatr Neurol Jpn; 1984; 38(4):445-9. PubMed ID: 6535745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The metyrapone test in schizophrenic patients and healthy subjects.
    Morphy MA; Fava GA; Carson SW; Perini GI; Molnar G; Jusko WJ
    Neuropsychobiology; 1985; 14(1):35-8. PubMed ID: 4069347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.